Authors




Evan Lantz, PharmD

Latest:

Passing the First Test: How to Impress on the Residency Interview

With more and more students applying for residency positions, off-site interviews are becoming an important first step in the selection process.



Jerry A. Barbee Jr, PharmD, BCPS, CPh

Latest:

Explore Ovarian Cancer Treatments Through Clinical Trials

Guidelines typically recommend debulking surgery, plus systemic chemotherapy for most patients.



Danielle M. Candelario, PharmD, BCPS

Latest:

Pharmacy and Telehealth: An Interprofessional Model at a Student-led Free Clinic

Unique model demonstrates how clinical pharmacy services could be integrated into an interprofessional telehealth clinic.



David W. Poole

Latest:

The Evolution of the HIV Epidemic and the Role of Pharmacists: Where Are We 35 Years Later?

In June of 1981 an unspeakable new disease entered the public consciousness in the United States and it did so quickly and unexpectedly, leaving illness, tragedy, and death in its wake.


Brian Onorato

Latest:

Zitter Health Insights and Specialty Pharmacy Times to Grant Awards in Specialty Pharmacy Customer Satisfaction

The Specialty Pharmacy Satisfaction Survey recognizes the top performing specialty pharmacies for achievements in customer satisfaction.


Jeffrey C. Lombardo, PharmD, BCOP

Latest:

Challenges and Innovations in the Manufacture of Hazardous Drugs

USP General Chapter , which was published by the United States Pharmacopeial Convention and updated most recently in December 2017, sets forth guidelines for the handling of hazardous drugs in the health care setting with the goal of promoting safety for patients and health care workers.


Melinda Haren, RN

Latest:

Increases in Utilization Management of Oncology Medicines by US Payers

Recent increases in the number of therapies indicated for a given oncology subtype has resulted in heightened utilization management stringency.



Maria Lopes, MD

Latest:

Budget Impact of Everolimus in Treating Metastatic Renal Cell Carcinoma

A decision-analytical model shows that everolimus has a favorable budget impact when introduced into the treatment algorithm for metastatic renal cell carcinoma.



Azza AbuDagga, PhD, MHA

Latest:

Real-World Dosing and Utilization of Ustekinumab Among Patients With Psoriasis

This study is an evaluation of the dosing patterns of ustekinumab among patients with psoriasis in a real-world setting.


Laura K. Sjoquist, PharmD Candidate

Latest:

ASD and Medication Adherence: An Opportunity for Pharmacist Intervention

Unfortunately, medication adherence in children with ASD is poor, particularly among children with chronic conditions or comorbid mental health conditions.


Debbie Eaton

Latest:

Industry Voice: Asking For What You Want: It Works

Ask for what you want. Seems simple, right?


Ann Johnson, PharmD

Latest:

The Value of Data in Specialty Pharmacy

Data have different meanings and value for each of the key stakeholders in specialty pharmacy. Understanding the needs of each group will help improve outcomes and reduce expenses.


Ron Lanton III, Esq

Latest:

Op-Ed: Why We Need a Health Promotion Screening Law in Massachusetts

Implementing screening and testing services by pharmacists will expand access to care for patients.


Sandra Kear

Latest:

Examining the Role of REMS in Opioid Safety

An expert questions why the risks and side effects of warfarin are explained much more carefully to patients than those of opioids.


Royce A. Burruss, RPh, MBA, FASCP

Latest:

New Roles for Oncology Pharmacists

These pharmacists have specialized knowledge about pharmaceuticals and their use in treating cancer and its comorbidities, and they work collaboratively with the health care team to optimize outcomes.


Won Chan Lee, PhD

Latest:

Costs of Collagenase Clostridium Histolyticum and Fasciectomy for Dupuytren's Contracture

A retrospective cohort analysis was conducted to compare disease-specific healthcare resource utilization and the costs of collagenase clostridium histolyticum and fasciectomy among adult Dupuytren’s contracture patients.


Abraham Weizman, MD

Latest:

Large-Scale, Community-Based Trial of a Personalized Drug-Related Problem Rectification System

A controlled trial of a system for rectifying and preventing drug-related problems was conducted to evaluate improvement in the efficiency of resource utilization.


Cecilia Pessoa Gingerich

Latest:

Acute Migraine Treatment Gets FDA Complete Response Letter

Rizaport is an oral film formulation of rizatriptan benzoate, the active drug in Maxalt, for patients with migraine who experience dysphagia or migraine-related nausea.



Anthony Omojasola, DrPH

Latest:

Impact of Generic Drug Discount Programs on Managed Care Organizations

Generic drug discount programs, which differ across large chain pharmacies, may result in significant savings for managed care organizations.


Julie B. Kessel, MD

Latest:

Clinical and Cost Outcomes of Buprenorphine Treatment in a Commercial Benefit Plan Population

Buprenorphine treatment with and without induction was found to decrease costs and utilization in opioid-dependent benefciaries.


Lauren Meyer, PharmD

Latest:

Trends in Medication Utilization and the Cost of Treatment for Gout

With new drugs in the pipeline and the impact of updated FDA drug safety policies on colchicine, gout may no longer be inexpensive to treat.


Panteha Mortazavi, PharmD

Latest:

Letter: Creating a Moment of Care

I truly enjoy and cherish when patients look into my eyes and see that there is no stereotyping, insensitivity, or indifference.